Guided Therapeutics (OTCMKTS:GTHP) Trading Up 1.4% – Here’s Why

by · The Cerbat Gem

Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report) shares were up 1.4% during mid-day trading on Wednesday . The stock traded as high as $0.2028 and last traded at $0.2028. Approximately 2,919 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 7,910 shares. The stock had previously closed at $0.20.

Guided Therapeutics Price Performance

The firm’s 50 day moving average is $0.21 and its two-hundred day moving average is $0.29. The company has a market cap of $19.58 million, a P/E ratio of -5.07 and a beta of 0.74.

Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last issued its earnings results on Friday, May 15th. The company reported ($0.01) EPS for the quarter.

About Guided Therapeutics

(Get Free Report)

Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.

The company secured 510(k) clearance from the U.S.

Read More